(Q53333711)

13 May 2018

title

Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. (English)

1 reference

13 May 2018

1 reference

M E Cromheecke

1

1 reference

13 May 2018

M Levi

2

1 reference

13 May 2018

L P Colly

3

1 reference

13 May 2018

B J de Mol

4

1 reference

13 May 2018

M H Prins

5

1 reference

13 May 2018

B A Hutten

6

1 reference

13 May 2018

R Mak

7

1 reference

13 May 2018

K C Keyzers

8

1 reference

13 May 2018

H R Büller

9

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

13 May 2018

published in

The Lancet

1 reference

13 May 2018

volume

356

1 reference

13 May 2018

issue

9224

1 reference

13 May 2018

page(s)

97-102

1 reference

13 May 2018

cites work

Oral anticoagulant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Management of oral anticoagulant therapy. Experience with an anticoagulation clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Prevention of one-year vein-graft occlusion after aortocoronary- bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Advances in the Monitoring of Oral Anticoagulation: Point-of-Care Testing, Patient Self-Monitoring, and Patient Self-Management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Empowering patients to monitor and manage oral anticoagulation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Long-term patient self-management of oral anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Self management of oral anticoagulant therapy after heart valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Training of patients for self-management of oral anticoagulant therapy: standards, patient suitability, and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Multicenter evaluation of a new capillary blood prothrombin time monitoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Clinical biostatistics. LIV. The biostatistics of concordance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Hemorrhagic complications of anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

The role of compliance as a cause of instability in oral anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Effectiveness of health education and health promotion: meta-analyses of effect studies and determinants of effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

Cost-effectiveness of self-managed anticoagulant therapy in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902470-3

7 January 2021

10.1016/S0140-6736(00)02470-3

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018